A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma

NCT00000681 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Bleomycin sulfate
DRUG: Vincristine sulfate
DRUG: Doxorubicin hydrochloride
DRUG: Zidovudine
DRUG: Sargramostim

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)